This is because reduced levels of tissue plasminogen activator (tPA) and plasmin, the two key enzymes required for the processing of proNGF, have been detected in the brains of patients with mild cognitive impairments (Bruno et al., 2009a). This evidence concerns the gene PLAT and Cognitive impairment.